Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1402 A potent, CD8 T cell targeted IL-2 A-Kine with a broad therapeutic window induces antitumor immunity in syngeneic and humanized mouse tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.
